Potential therapeutic strategies for lymphatic metastasis
- 1 September 2007
- journal article
- review article
- Published by Elsevier in Microvascular Research
- Vol. 74 (2-3) , 145-158
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancerBritish Journal of Cancer, 2007
- Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancerProteomics, 2006
- First international consensus on the methodology of lymphangiogenesis quantification in solid human tumoursBritish Journal of Cancer, 2006
- COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancerBritish Journal of Cancer, 2006
- Neuropilins in neoplasms: Expression, regulation, and functionExperimental Cell Research, 2006
- Angiopoietins in tumours: the angiogenic switchThe Journal of Pathology, 2004
- The anti-angiogenic basis of metronomic chemotherapyNature Reviews Cancer, 2004
- Expression of vascular endothelial growth factor (VEGF)‐C and VEGF‐D, and their receptor VEGFR‐3, during different stages of cervical carcinogenesisThe Journal of Pathology, 2003
- Genetic loci that control vascular endothelial growth factor‐induced angiogenesisThe FASEB Journal, 2003
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971